Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TRPV3 inhibitor (Salipro Biotech)
- Development stage
- Preclinical
- Lead developer
- Salipro Biotech
- Modality
- Small Molecules
01
Overview
TRPV3 inhibitor (Salipro Biotech) is a preclinical-stage therapeutic candidate being developed by Salipro Biotech for the treatment of CNS-related pain. The program targets the Transient Receptor Potential Vanilloid 3 (TRPV3) ion channel, a calcium-permeable non-selective cation channel involved in thermosensation and nociception. Salipro Biotech utilizes its proprietary Salipro® technology to stabilize the multi-pass transmembrane TRPV3 protein in a native-like lipid environment, which facilitates the discovery and development of potent and selective modulators. By inhibiting TRPV3 activity in the central nervous system, the drug aims to provide a novel analgesic approach for managing chronic pain conditions.
- Other names
- Salipro Biotech TRPV3 program
02
Targets
TRPV3 (Transient receptor potential vanilloid subtype 3)
Beyond the preview
Go deeper on TRPV3 inhibitor (Salipro Biotech).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TRPV3 inhibitor (Salipro Biotech).